4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001742084-26-000003
CEO sold 5,124 shares at $3.04 ($15,563)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'Neill Gilmore Neil · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-03 | Sale : show line 1 in the form 10b5-1 | −5,124 | $3.04 | $15,563 | 243,189 | D |
| Open-market sales · 5,124 sh · avg $3.04 · $15,563 | ||||||
Loading xslF345X06/wk-form4_1788553359.xml…